The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 13, 2025

Filed:

Oct. 03, 2023
Applicant:

Realta Holdings, Llc, Norfolk, VA (US);

Inventors:

Neel K. Krishna, Norfolk, VA (US);

Kenji Cunnion, Norfolk, VA (US);

Assignee:

REALTA HOLDINGS, LLC, Norfolk, VA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 38/16 (2006.01); A61K 47/60 (2017.01); A61P 7/00 (2006.01); A61P 25/00 (2006.01); A61P 37/06 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 38/162 (2013.01); A61K 47/60 (2017.08); A61P 7/00 (2018.01); A61P 25/00 (2018.01); A61P 37/06 (2018.01); A61K 38/00 (2013.01); C12N 2770/12022 (2013.01); C12N 2770/12033 (2013.01); C12N 2770/12071 (2013.01);
Abstract

The present invention provides synthetic peptide compounds and uses thereof for therapy and diagnostics of complement-mediated diseases, such as inflammatory diseases, autoimmune diseases, and microbial and bacterial infections; and non-complement-mediated diseases, such cystic fibrosis and various acute diseases. The invention is directed to modifications of a synthetic peptide of 15 amino acids from the Polar Assortant (PA) peptide, which is a scrambled peptide derived from human Astrovirus protein. In some embodiments, the invention is directed to peptide compounds that are peptide mimetics, peptide analogs and/or synthetic derivatives of PA (e.g., sarcosine derivatives) having, for example, internal peptide substitutions, and modifications, including PEGylation at the N-terminus and C-terminus. The invention further provides methods of selecting at least one synthetic peptide for treating various conditions.


Find Patent Forward Citations

Loading…